Introduction to Wt1
Exploring Wt1 reveals several interesting facts. Margaret Gatti-Mays, MD MPH, The Ohio State University, Columbus, OH, discusses findings from a Phase I study of B440, an oral ...
Wt1 Comprehensive Overview
Marion Subklewe, MD, Ludwig Maximilian University Hospital Munich, Munich, Germany, discusses her work investigating ... Himachandana Atluri, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, speaks on a retrospective study ... Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, discusses outcomes of allogeneic stem cell transplantation ...
Marion Subklewe, MD, LMU Hospital Munich, Munich, Germany, outlines a study evaluating a 2+1 T-cell bispecific (TCB) antibody ...
Summary & Highlights for Wt1
- WT1
- T cell receptor (TCR)–modified T cell therapies show clinical potential for the treatment of different cancers however a key ...
- 2026 ORCATAB
- Sanam Loghavi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, speaks on a study examining the ...
- WT1
Stay tuned for more updates related to Wt1.
